News Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
28.23 ^USD	-0.14%		+8.20%	+23.11%

07/05	Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/04	Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing	MT

503aaf7d27befe50.T1lfyvS1I36j_5yRKLDYYNzcfnrpmcuyXfhg6ymz_5g.fxIGn7PNdSrAs-TnR-qyNbjsTyDR9JzXJ7wYphHEq_srAXKQt89BTpDGpA~0a0d2a099f4f66833f213d8189a25479